The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.

Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.

The best treatment for multifaceted diseases like NASH may be combinations of drugs.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients

At Novartis, we celebrate life and recognize moments that matter. Alfred Ambatlle shares his experience of parental leave and becoming a father of twins.

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

Ann Aerts has stared death in the eye. The head of the non-profit Novartis Foundation lost colleagues when she was serving as an emergency medicine physician on a medical mission in a dangerously unstable country.

A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.